The CBIS stock chart is holding a base at a nickel after sliding from recent highs near 14 cents in February. We have changed the format of our videos and are focused on a MACD and RSI that are looking to turn as the support is being held with resistance coming at 6 cents.
Video Rating: 5 / 5
World’s Deadliest Drugs
Image by mkandlez
Last week, the UK government has sacked its most senior drugs advisor, Dr Professor Nutt, after he claimed cannabis was no more harmful than alcohol. And that horse-riding was riskier than taking ecstasy.
(Technically he’s right. The lifetime odds of dying from ecstasy overdose is 1 in 17,803. The risk of dying from horse-riding is around double – 1 in 7,833.)
Taking the science behind his statement and mashing it up with press coverage of drug risks creates an interesting picture.
News Recap – Crosswind Renewable Energy (CWNR), Cannabis Science (CBIS …
Stamford, Connecticut – 11th March 2015 – (Techsonian) – Thousands of penny stock investors use the Jet Life Penny Stocks newsletter and our web based technologies that highlight picks and profiles the hottest penny stocks for trading. While we never …
Read more on Techsonian (press release)
Penny Stock's Morning Buzz-Cannabis Science (CBIS), SABMiller (SBMRY …
Cannabis Science Inc(OTCMKTS:CBIS) opened the session at $ 0.05, trading in a range of $ 0.0495 – $ 0.05, and was at $ 0.05. The stock showed a positiveperformance of +1.21% in the recent trading session. The stock was trading on a volume of 0.776 …
Read more on Investor Wired
Morning Buzzers – Qihoo 360 Technology (QIHU),Cannabis Science (CBIS …
Manhattan, NY- March 10, 2015 – (Techsonian) –Qihoo 360 Technology Co Ltd (NYSE:QIHU)stated its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2014. Revenues were $ 431.2 million, a 94.6% raise from $ 221.6 …
Read more on Techsonian (press release)
Chicago, IL (PRWEB) February 21, 2015
“We the People is a higher thought,” opened Bryan W. Brickner, “and the serotonin system is fundamental to all thoughts.”
In We the People and Synaptic Serotonin (5-HT) Science, a new update on the Bryan William Brickner Blog, the focus is serotonergic homeostasis, with particular attention on the central nervous system. In January, Brickner published Shivitti: A Review of Ka-Tzetnik 135633’s Vision, a serotonin system (lysergic acid, LSD) book review on healing Auschwitz nightmares. Today’s post continues the serotonin and healing – for all people – storyline with new 2015 science from the National Institutes of Health (PubMed), which highlights: selective serotonin reuptake inhibitors (SSRIs) and obsessive-compulsive disorder (OCD), 5-HT3 receptors and OCD, prefrontal cortex (brain) and 5-HT2A receptors, and genetic research on suicide and the serotonin transporter gene (5-HTT, SERT).
“There are two today on OCD,” explained Brickner, “with one on the robust data supporting the effectiveness of treatment with selective serotonin reuptake inhibitors (SSRIs), the acknowledged first-line pharmacological treatment of choice.”
“The second OCD serotonin report is scanty,” Brickner continued, “as the research is hampered by a lack of data; the scientific interest is in the serotonin 5-HT3 receptor and OCD patients – though a PubMed review only turned up six publications on the topic, not enough to draw valid conclusions.”
“For the brain serotonin science,” noted Brickner, “research shows the 5-HT2A receptors in the prefrontal cortex regulating dopamine release; this stimulates a ‘long-loop’ feedback system from the cortex to other parts of the brain … and back.”
“With suicide and the serotonin transporter, SERT,” Brickner closed, “the science shows only a small genetic association while pointing out the politically obvious: the serotonin system is part of every suicide solution.”
Brickner has a 1997 political science doctorate from Purdue University and is the author of several political theory books, to include: The Promise Keepers: Politics and Promises (1999), Article the first of the Bill of Rights (2006), and Shivitti: A Review of Ka-Tzetnik 135633’s Vision (2015). He also writes political fiction, such as the novella thereafter (2013), and is the publisher of The Cannabis Papers: A citizen’s guide to cannabinoids (2011) and The Bryan William Brickner Blog, a resource for the political science of constitutions and the biological science of receptors.
Next Ew Publishing: Tomorrow, Sunday 22 February, We the People, Publius and Homeostatic Cannabinoids.
San Francisco, CA (PRWEB) February 24, 2015
United Patients Group, a go-to resource for news and information on medical cannabis, is thrilled to share the lineup of presenters for the upcoming educational seminar for nurses “ACNA Core Curriculum for Cannabis Nursing,” which will be hosted by Laguna Woods Village Cannabis Club (LWVCC) located in Laguna Woods Village, Clubhouse 5 on March 17, 2015, in Laguna Woods, California. This seminar offers 6 contact hours, presented by the American Cannabis Nurses Association (ACNA), will feature in-depth explorations of the science behind and application of cannabinoid medicine by nurses at the forefront of this movement.
“Nurses across the country and around the world are embracing the use of medicinal cannabis to treat patients with a wide variety of ailments,” explains John Malanca, founder of United Patients Group. “This conference will present the latest findings and clinical recommendations from some of the most knowledgeable cannabis nurses working today.”
Presentations will include:
History of Medical Cannabis Use – Alice O’Leary-Randall, LPN, CT
Medical Cannabis Cultivation: Basics for Nurses – Eileen Konieczny, RN, and Heather Manus, RN
The Endocannabinoid System – Cecilia Hillard
Clinical Applications in Medical – Surgical Nursing – Leslie Reyes, RN
Clinical Applications in Mental Health Nursing – Heather Manus, RN
Side Effects and Medical Risks Related to Cannabis Use – Marcie Cooper, RN, MSN, AHN-BC
Cannabis Dosage and Administration, and the Healthy Benefits of Hemp – Eloise Theisen, RN, MSN, AGPCNP
Legal and Social Risks Related to Cannabis Use – Eileen Konieczny, RN, and Heather Manus, RN
Cannabis Risk of Addiction and Interaction with Opioids – Mary Lynn Mathre, RN, MSN, CARN
Clinical Implications for Nurses – Eileen Konieczny, RN
“By attending this conference, you will get a thorough exploration of the history, science, legality, and administration of cannabinoid medicine,” says Malanca. “If you’re looking for a safe, effective way to help your patients feel better, you should not miss this event.”
The seminar will take place from 9 a.m. to 4 p.m. on March 17, 2015, at the Laguna Woods Village Clubhouse 5, a retirement community in Laguna Woods, California. It is eligible for six contact hours of continuing educational credits through the Ohio Nurses Association. * The ACNA member rate is $ 195, including contact hours. The non-member rate is $ 175 for those not seeking contact hours or $ 295 including contact hours. A discounted hotel rate of $ 129+ tax is available at the Ayres Hotel Laguna Woods. Register online at http://americancannabisnursesassociation.org/event-1846996.
*“This continuing nursing education activity was approved by the Ohio Nurses Association (OBN-001-91), an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Approval valid through 5/08/2016. Assigned ONA #17207.”
For more information about cannabinoid medicine, go to http://www.UnitedPatientsGroup.com.
About United Patients Group:
United Patients Group is a discreet, safe, and professional online medical cannabis information resource for prospective and current patients, caregivers, and medicinal cannabis industry professionals.
While most online medical cannabis sites cater to patients already familiar with medical cannabis, the UnitedPatientsGroup.com website is a comprehensive and easy-to-use information source for people of all ages and experience levels, from novice users to experienced industry professionals. The site’s News, Resource, and Blog pages introduce new patients to the ins and outs of medical cannabis healthcare, while helping experienced providers stay abreast of the latest developments in THC and CBD therapies.
A complimentary five-star-rated United Patients Group medical cannabis app is available on the iTunes app store for iPhone 3GS, iPhone 4, iPhone 4S, iPhone 5, iPod touch (3rd generation), iPod touch (4th generation), and any iPad.
Find More Cannabis Science Press Releases
Chicago, IL (PRWEB) February 24, 2015
Ew Publishing announces Hannah Arendt Footnotes, a 21st century political theory series celebrating her 1958 book, The Human Condition.
The new series on the Bryan William Brickner Blog highlights and celebrates Arendt’s 1958 book via its 21st century applicability. In the first posting, Arendt Footnotes: Marx, Violence and the American Revolution, modernity’s glorification of violence is noted with one exception: 1776.
“Arendt writes as a classic,” offered Ew Publishing’s Bryan W. Brickner, “meaning at the height of the times; she was run out of Germany by fascism, has citizenship in America, and gives back – to generations – with her teachings.”
In January, Brickner published Shivitti: A Review of Ka-Tzetnik 135633’s Vision (2015), and acknowledged Arendt’s work in his book; specifically, the role of otherness in violence.
“Arendt notes that the revolutions of the modern age,” continued Brickner, “share a common (Roman) enthusiasm for politics and the glorification of violence; she makes one exception though, for the American Revolution.”
“In living as a modern before post-modernism,” Brickner closed, “Arendt theorizes with self-assured acuity; often more than most are accustomed to: for example, her Marx hits the mark.”
Brickner has a 1997 political science doctorate from Purdue University and is the author of several political theory books, to include: The Promise Keepers: Politics and Promises (1999), Article the first of the Bill of Rights (2006), and Shivitti: A Review of Ka-Tzetnik 135633’s Vision (2015). He also writes political fiction, such as the novella thereafter (2013), and is the publisher of The Cannabis Papers: A citizen’s guide to cannabinoids (2011) and The Bryan William Brickner Blog, a resource for the political science of constitutions and the biological science of receptors.
Next Ew Publishing: Friday, 27 February, Black History, American Exceptionalism and Carl Sandburg’s Chicago of 1919, a William Abens special on the Bryan William Brickner Blog.
Chicago, IL (PRWEB) January 31, 2015
“Teamwork is homeostasis,” opened Bryan W. Brickner, “and it’s the little things that count – that create the conditions for any game-winning moment.”
In Teamwork: Publius’ Super Bowl of Cannabinoid Science ~ New Homeostasis on the Bryan William Brickner Blog, today’s spotlight celebrates the little things – in sports as in life – that function without acclaim. Publius, of The Cannabis Papers: A citizen’s guide to cannabinoids (2011), showcases four recent PubMed cannabinoid system (CS) articles discussing: management of neuroinflammatory (brain) disorders, CB1 anti-aversive panic properties, obesity and the therapeutic agents THCV and CBD, and cannabinoids as a tool in modern cancer pharmacotherapy.
“Cannabinoid signaling in the brain,” noted Brickner, “is endowed with significant immunoregulatory and anti-inflammatory properties; the reviewed science shows this to be in both peripheral tissues and in the CNS, indicating a CS role in the management of brain disorders.”
“The panic controlling actions of cannabinoids will be evident Sunday,” Brickner chuckled, “and the new science tells how our CB1 receptors have a direct impact.”
“The obesity update shows two cannabinoids, THCV and CBD,” continued Brickner, “with positive results in treating hepatosteatosis, a liver disease.”
“Cannabinoids benefiting chemotherapeutics,” closed Brickner, “continues the CS anti-cancer narrative; the PubMed abstract notes the teamwork nature of cannabinoids and sees them as a player in modern cancer pharmacotherapy.”
Brickner has a 1997 political science doctorate from Purdue University and is the author of several political theory books, to include: The Promise Keepers: Politics and Promises (1999), Article the first of the Bill of Rights (2006), and Shivitti: A Review of Ka-Tzetnik 135633’s Vision (2015). He also writes political fiction, such as the novella thereafter (2013), and is the publisher of The Cannabis Papers: A citizen’s guide to cannabinoids (2011) and The Bryan William Brickner Blog, a resource for the political science of constitutions and the biological science of receptors.
The Cannabis Papers is available at online retailers and for free by download.
Related Cannabis Press Releases
his is definitely the best Marijuana / Marihuana / Weed Documentar you will ever watch in your life!. ENJOY! =)
Cannabis
From Wikipedia, the free encyclopedia
This article is about the plant genus. For use as a psychoactive drug, see Cannabis (drug). For other uses, see Cannabis (disambiguation).
Cannabis (/ˈkænəbɪs/) is a genus of flowering plants that includes three putative varieties, Cannabis sativa,[1] Cannabis indica,[1] and Cannabis ruderalis. These three taxa are indigenous to Central Asia, and South Asia.[2] Cannabis has long been used for fibre (hemp), for seed and seed oils, for medicinal purposes, and as a recreational drug. Industrial hemp products are made from Cannabis plants selected to produce an abundance of fiber. To satisfy the UN Narcotics Convention, some Cannabis strains have been bred to produce minimal levels of THC, the principal psychoactive constituent responsible for the “high” associated with marijuana. Marijuana consists of the dried flowers of Cannabis plants selectively bred to produce high levels of THC and other psychoactive cannabinoids. Various extracts including hashish and hash oil are also produced from the plant.[3]
=============================================
Description
Cannabis is an annual, dioecious, flowering herb. The leaves are palmately compound or digitate, with serrate leaflets.[9] The first pair of leaves usually have a single leaflet, the number gradually increasing up to a maximum of about thirteen leaflets per leaf (usually seven or nine), depending on variety and growing conditions. At the top of a flowering plant, this number again diminishes to a single leaflet per leaf. The lower leaf pairs usually occur in an opposite leaf arrangement and the upper leaf pairs in an alternate arrangement on the main stem of a mature plant.
The leaves have a peculiar and diagnostic venation pattern that enables persons poorly familiar with the plant to distinguish a Cannabis leaf from unrelated species that have confusingly similar leaves (see illustration). As is common in serrated leaves, each serration has a central vein extending to its tip. However,the serration vein originates from lower down the central vein of the leaflet, typically opposite to the position of, not the first notch down, but the next notch. This means that on its way from the midrib of the leaflet to the point of the serration, the vein serving the tip of the serration passes close by the intervening notch. Sometimes the vein will actually pass tangent to the notch, but often it will pass by at a small distance, and when that happens a spur vein (occasionally a pair of such spur veins) branches off and joins the leaf margin at the deepest point of the notch. This venation pattern varies slightly among varieties, but in general it enables one to tell Cannabis leaves from superficially similar leaves without difficulty and without special equipment. Tiny samples of Cannabis plants also can be identified with precision by microscopic examination of leaf cells and similar features, but that requires special expertise and equipment.[10]
Cannabis normally has imperfect flowers, with staminate “male” and pistillate “female” flowers occurring on separate plants.[11] It is not unusual, however, for individual plants to bear both male and female flowers.[12] Although monoecious plants are often referred to as “hermaphrodites,” true hermaphrodites (which are less common) bear staminate and pistillate structures on individual flowers, whereas monoecious plants bear male and female flowers at different locations on the same plant. Male flowers are normally borne on loose panicles, and female flowers are borne on racemes.[13] “At a very early period the Chinese recognized the Cannabis plant as dioecious,”[14] and the (ca. 3rd century BCE) Erya dictionary defined xi 枲 “male Cannabis” and fu 莩 (or ju 苴) “female Cannabis”.[15]
All known strains of Cannabis are wind-pollinated[16] and the fruit is an achene.[17] Most strains of Cannabis are short day plants,[16] with the possible exception of C. sativa subsp. sativa var. spontanea (= C. ruderalis), which is commonly described as “auto-flowering” and may be day-neutral.
Tags:
marijuana documentary,marijuana documentary 2013,marijuana documentary history channel,marijuana documentary national geographic,marijuana documentary 2012,marijuana documentary bbc,marijuana documentary canada,marijuana documentary this month,documentary marijuana,documentary marihuana,marihuana documentary,grass documentary,grass documentary full,weed,weed documentary,weed documentary 2013,weed documentary history channel,weed documentary national geographic
Video Rating: 4 / 5
Santa Cruz, california (PRWEB) February 28, 2015
In recent years Medical Marijuana has continuously been embraced by an ever growing number of practicing physicians as a way for them to expand their patient base without any real experience, training or education regarding Cannabis as medicine. Since the FDA still lists Cannabis as a Schedule 1 drug, there have been very few resources available to licensed physicians that can help guide them when recommending a Cannabis related treatment to a patient. Dr. Deborah Malka in Santa Cruz, CA is a leader in the small, but growing number of Medical Professionals that are aware of this issue and working to rectify the problem.
Dr. Malka’s practice is called Cannabis Plus and is located in Santa Cruz and Monterey, CA. She, in addition to being a licensed MD, is also Board Certified in Integrative Holistic Medicine. Dr. Malka has spent years working with Medical Cannabis Patients. While many doctors are willing to recommend Medical Cannabis as a treatment, few offer the same level of knowledge and experience as Dr. Malka. Each patient that visits Cannabis Plus is thoroughly interviewed regarding their medical history as well as their daily lifestyle in order for Dr. Malka to consult in proper usage, dosage and knowledge of exactly how to treat their individual conditions. Patients are also encouraged to return to her for follow up consultations to make sure that they are getting the best results possible.
Dr. Malka’s approach to medicine has allowed her to develop a unique level of experience and understanding regarding Medical Cannabis. While it is valuable in treating her own patients for a vast range of issues from cancer to autism, she has also proved a strong desire to share her knowledge and experience with other medical professionals. She is an officer of the Society of Cannabis Clinicians and has helped to develop the first CME(Continuing Medical Education) curriculum available to provide medical professionals with a greater understanding of Cannabis as medicine as well as twelve credits toward their CME requirement.
In a growing area of medicine that is still more about politics than science, Dr. Deborah Malka is serving the Medical Cannabis movement with her passion, clarity, and expertise.
Video was uploaded by Cannabis Science Magazine in California
Source found here https://www.youtube.com/cannabisscience
Video Rating: 5 / 5
PLEASE WATCH AND SHARE THIS VIDEO
NEW Documentary – http://youtu.be/XfO_MpDm5kc
Legalize Cannabis – http://petition.liberal.ca/end-prohibition
–
Cannabinoid Research
–
ncbi.nlm.nih.gov/pmc/articles/PMC3442177
ncbi.nlm.nih.gov/pmc/articles/PMC2828614
ncbi.nlm.nih.gov/pmc/articles/PMC2604798
ncbi.nlm.nih.gov/pmc/articles/PMC2872061
ncbi.nlm.nih.gov/pmc/articles/PMC2225529
ncbi.nlm.nih.gov/pmc/articles/PMC2812803
ncbi.nlm.nih.gov/pmc/articles/PMC2277494
ncbi.nlm.nih.gov/pmc/articles/PMC2823358
ncbi.nlm.nih.gov/pmc/articles/PMC2898685
ncbi.nlm.nih.gov/pmc/articles/PMC2925907
ncbi.nlm.nih.gov/pmc/articles/PMC2819831
ncbi.nlm.nih.gov/pmc/articles/PMC2936031
ncbi.nlm.nih.gov/pmc/articles/PMC2866040
ncbi.nlm.nih.gov/pmc/articles/PMC2829220
ncbi.nlm.nih.gov/pmc/articles/PMC3023979
ncbi.nlm.nih.gov/pmc/articles/PMC2936031
ncbi.nlm.nih.gov/pmc/articles/PMC3034694
ncbi.nlm.nih.gov/pmc/articles/PMC3230631
ncbi.nlm.nih.gov/pmc/articles/PMC3232190
ncbi.nlm.nih.gov/pmc/articles/PMC3165947
ncbi.nlm.nih.gov/pmc/articles/PMC3096803
ncbi.nlm.nih.gov/pmc/articles/PMC2071638
ncbi.nlm.nih.gov/pmc/articles/PMC1892413
ncbi.nlm.nih.gov/pmc/articles/PMC2270485
ncbi.nlm.nih.gov/pmc/articles/PMC1592672
ncbi.nlm.nih.gov/pmc/articles/PMC2430692
ncbi.nlm.nih.gov/pmc/articles/PMC2189767
ncbi.nlm.nih.gov/pmc/articles/PMC2664885
ncbi.nlm.nih.gov/pmc/articles/PMC2765124
ncbi.nlm.nih.gov/pmc/articles/PMC2737440
ncbi.nlm.nih.gov/pmc/articles/PMC2955420
ncbi.nlm.nih.gov/pmc/articles/PMC2682269
ncbi.nlm.nih.gov/pmc/articles/PMC2451037
ncbi.nlm.nih.gov/pmc/articles/PMC2592995
ncbi.nlm.nih.gov/pmc/articles/PMC3316151
ncbi.nlm.nih.gov/pubmed/19638490
ncbi.nlm.nih.gov/pubmed/22776349
ncbi.nlm.nih.gov/pubmed/16682966
ncbi.nlm.nih.gov/pubmed/12648025
ncbi.nlm.nih.gov/pubmed/19914218
ncbi.nlm.nih.gov/pubmed/16893424
ncbi.nlm.nih.gov/pubmed/15361550
ncbi.nlm.nih.gov/pubmed/19889794
ncbi.nlm.nih.gov/pubmed/19015962
ncbi.nlm.nih.gov/pubmed/19608284
ncbi.nlm.nih.gov/pubmed/17237277
ncbi.nlm.nih.gov/pubmed/11586361
ncbi.nlm.nih.gov/pubmed/14692532
ncbi.nlm.nih.gov/pubmed/16571653
ncbi.nlm.nih.gov/pubmed/18286801
ncbi.nlm.nih.gov/pubmed/16250836
ncbi.nlm.nih.gov/pubmed/17934890
ncbi.nlm.nih.gov/pubmed/12052046
ncbi.nlm.nih.gov/pubmed/19189054
ncbi.nlm.nih.gov/pubmed/18354058
ncbi.nlm.nih.gov/pubmed/19047095
ncbi.nlm.nih.gov/pubmed/10913156
ncbi.nlm.nih.gov/pubmed/9653194
ncbi.nlm.nih.gov/pubmed/18088200
ncbi.nlm.nih.gov/pubmed/16909207
ncbi.nlm.nih.gov/pubmed/17342320
ncbi.nlm.nih.gov/pubmed/19059457
ncbi.nlm.nih.gov/pubmed/12723496
ncbi.nlm.nih.gov/pubmed/19442536
ncbi.nlm.nih.gov/pubmed/16728591
ncbi.nlm.nih.gov/pubmed/19539619
ncbi.nlm.nih.gov/pubmed/16500647
ncbi.nlm.nih.gov/pubmed/19189659
ncbi.nlm.nih.gov/pubmed/14617682
ncbi.nlm.nih.gov/pubmed/18938775
ncbi.nlm.nih.gov/pubmed/11106791
ncbi.nlm.nih.gov/pubmed/19394652
ncbi.nlm.nih.gov/pubmed/20336665
ncbi.nlm.nih.gov/pubmed/19442435
ncbi.nlm.nih.gov/pubmed/15451022
ncbi.nlm.nih.gov/pubmed/18197164
ncbi.nlm.nih.gov/pubmed/16835997
ncbi.nlm.nih.gov/pubmed/11903061
ncbi.nlm.nih.gov/pubmed/17675107
ncbi.nlm.nih.gov/pubmed/17202146
ncbi.nlm.nih.gov/pubmed/19425170
ncbi.nlm.nih.gov/pubmed/18454173
ncbi.nlm.nih.gov/pubmed/17065222
ncbi.nlm.nih.gov/pubmed/10700234
ncbi.nlm.nih.gov/pubmed/16787257
ncbi.nlm.nih.gov/pubmed/15958274
ncbi.nlm.nih.gov/pubmed/16139274
ncbi.nlm.nih.gov/pubmed/16624285
ncbi.nlm.nih.gov/pubmed/16616335
ncbi.nlm.nih.gov/pubmed/11269508
ncbi.nlm.nih.gov/pubmed/19690545
ncbi.nlm.nih.gov/pubmed/12511587
ncbi.nlm.nih.gov/pubmed/20307616
ncbi.nlm.nih.gov/pubmed/16818634
ncbi.nlm.nih.gov/pubmed/17952650
ncbi.nlm.nih.gov/pubmed/16818650
ncbi.nlm.nih.gov/pubmed/16596790
ncbi.nlm.nih.gov/pubmed/15638794
ncbi.nlm.nih.gov/pubmed/15275820
ncbi.nlm.nih.gov/pubmed/12133838
ncbi.nlm.nih.gov/pubmed/18339876
ncbi.nlm.nih.gov/pubmed/9771884
ncbi.nlm.nih.gov/pubmed/10570948
ncbi.nlm.nih.gov/pubmed/12182964
ncbi.nlm.nih.gov/pubmed/19229996
ncbi.nlm.nih.gov/pubmed/20546877
ncbi.nlm.nih.gov/pubmed/19916793
ncbi.nlm.nih.gov/pubmed/21464819
ncbi.nlm.nih.gov/pubmed/9392925
ncbi.nlm.nih.gov/pubmed/19394652
ncbi.nlm.nih.gov/pubmed/20336665
ncbi.nlm.nih.gov/pubmed/21312237
ncbi.nlm.nih.gov/pubmed/23318578
ncbi.nlm.nih.gov/pubmed/21807457
ncbi.nlm.nih.gov/pubmed/21298280
ncbi.nlm.nih.gov/pubmed/22447182
ncbi.nlm.nih.gov/pubmed/23361273
ncbi.nlm.nih.gov/pubmed/16500647
google.com/patents/US4837228
google.com/patents/US4189491
google.com/patents/US5631297
google.com/patents/US6132762
google.com/patents/US6410588
google.com/patents/US6630507
google.com/patents/US7741365
google.com/patents/US7597910
google.com/patents/US8071641
google.com/patents/US8242178
google.com/patents/US8034843
cmcr.ucsd.edu
phoenixtears.ca
thesethgroup.org
herb.com/guzman.pdf
cannabis-med.org/index.php?lng=en
gwpharm.com/cannabinoids-science.aspx
phoenixtearsfoundation.com/scientific-studies
Video Rating: 4 / 5